Page last updated: 2024-10-16

aminolevulinic acid and Bilateral Headache

aminolevulinic acid has been researched along with Bilateral Headache in 2 studies

Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.

Research Excerpts

ExcerptRelevanceReference
"Headache is common in PRES, though headache associated with PRES was not identified as a separate entity in the 2018 International Classification of Headache Disorders."2.72Posterior Reversible Encephalopathy Syndrome. ( Gao, V; Gewirtz, AN; Parauda, SC; Robbins, MS, 2021)
"Associations with PRES include renal failure, preeclampsia and eclampsia, autoimmune conditions, and immunosuppression."2.72Posterior Reversible Encephalopathy Syndrome. ( Gao, V; Gewirtz, AN; Parauda, SC; Robbins, MS, 2021)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Gewirtz, AN1
Gao, V1
Parauda, SC1
Robbins, MS1
Hoeflmayr, J1
Fried, R1
Wildgruber, R1

Reviews

1 review available for aminolevulinic acid and Bilateral Headache

ArticleYear
Posterior Reversible Encephalopathy Syndrome.
    Current pain and headache reports, 2021, Feb-25, Volume: 25, Issue:3

    Topics: Acute Chest Syndrome; Aminolevulinic Acid; Anemia, Sickle Cell; Autoimmune Diseases; Blood-Brain Bar

2021

Other Studies

1 other study available for aminolevulinic acid and Bilateral Headache

ArticleYear
[A simple photometric test for the routine determination of delta-aminolaevulinic acid in urine for the control of lead exposure].
    Deutsche medizinische Wochenschrift (1946), 1975, Jan-31, Volume: 100, Issue:5

    Topics: Aminolevulinic Acid; Buffers; Fatigue; Feeding and Eating Disorders; Headache; Humans; Indicators an

1975